<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02883569</url>
  </required_header>
  <id_info>
    <org_study_id>LBP</org_study_id>
    <nct_id>NCT02883569</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness Study for Surgery vs. Non-Surgery in Patients With Low Back Pain</brief_title>
  <acronym>CES_SNS_LBP</acronym>
  <official_title>Randomized Control Trial. Comparative Effectiveness Study for Surgery vs. Non-Surgery in Patients With Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gangnam Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University Guro Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: Comparative effectiveness research (CER) between surgical and non-surgical treatment
      for patients with low back pain Hypothesis: There will be significant differences in surgical
      and non-surgical treatment effect in patients who need operation for herniated intervertebral
      disc and spinal stenosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Eighty percents of the total population experiences lower back pain (LBP).
      Prevalence of LBP is about 20 to 30%. LBP is the most frequent disease and causes a lot of
      the medical and social costs. Recently the traditional drug therapy, exercise therapy has
      been developed and various non-surgical treatments have been developed. Surgical techniques
      are also rapidly evolving. In Korea lumbar spine surgeries were performed in accordance with
      the national practice guidelines presented by the Health Insurance Review and Assessment
      Service. Many patients who do not meet the surgical criteria undergo the non-surgical
      treatment, but there is no reliable research data for a systematic and cost-effective results
      of non-surgical treatment. It will be a big part of the future medical expenses because there
      is no guideline for the expensive procedure.

      Contents:

        1. Prospective randomized controlled trials to evaluate effectiveness and efficacy between
           surgical vs. non-surgical treatment for optimal treatment of low back pain

        2. Prospective observational clinical study for non-surgical treatment methods

        3. Analysis of health insurance data

        4. Comprehensive symposium

        5. Provide guideline for optimal treatment of low back pain

        6. The results will be used to reflect National health insurance policy Development
           Results: Suggestion of guideline for optimal treatment of low back pain through analysis
           of efficacy and effectiveness between treatments
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the change of pain score after treatment</measure>
    <time_frame>baseline and 24 months after treatment.</time_frame>
    <description>Visual analog scale (VAS) is decresed more than 2.5 or VAS is less than 3.5.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Appropriate conservative treatment period</measure>
    <time_frame>1, 3, 6, 12, 24 months after treatment.</time_frame>
    <description>Appropriate conservative treatment period, Cost-effectiveness analysis (Quality of life index (SF-36, EQ-5D-5L), Direct medical cost)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the change of pain score (Visual anlogue pain score) after time of treatment</measure>
    <time_frame>1, 3, 6, 12, 24 months after treatment.</time_frame>
    <description>compare the trend of change with mixed-model</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>24 month after treatment</time_frame>
    <description>Compare direct cost after each treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life index (SF-36)</measure>
    <time_frame>1, 3, 6, 12, 24 months after treatment.</time_frame>
    <description>compare the trend of change with mixed-model</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life index (EQ-5D-5L)</measure>
    <time_frame>1, 3, 6, 12, 24 months after treatment.</time_frame>
    <description>compare the trend of change with mixed-model</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">1102</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>HIVD-OP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>open or endoscopic discectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>epidural block, epidural adhesiolysis, exercise, ibuprofen, naxoprofen, Cox-2 inhibitor, aceclofenac, codeine, oxycontine, IRcodone, Tramadol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSS w/o instability -OP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>decompression, instrumentation and fusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>epidural block, epidural adhesiolysis, exercise, ibuprofen, naxoprofen, Cox-2 inhibitor, aceclofenac, codeine, oxycontine, IRcodone, Tramadol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSS w/ instability - OP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>decompression, instrumentation and fusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>epidural block, epidural adhesiolysis, exercise, ibuprofen, naxoprofen, Cox-2 inhibitor, aceclofenac, codeine, oxycontine, IRcodone, Tramadol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>exercise, ibuprofen, naxoprofen, Cox-2 inhibitor, aceclofenac, codeine, oxycontine, IRcodone, Tramadol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>epidural block, epidural adhesiolysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open or endoscopic discectomy</intervention_name>
    <description>FDA approved surgical procedures</description>
    <arm_group_label>HIVD-OP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>epidural block</intervention_name>
    <description>epidural block</description>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>exercise</intervention_name>
    <description>educated exercise</description>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_label>No intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ibuprofen, naxoprofen, Cox-2 inhibitor, aceclofenac</intervention_name>
    <description>FDA approved medication such as ibuprofen, naxoprofen etc.</description>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_label>No intervention group</arm_group_label>
    <other_name>NSAID</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>decompression</intervention_name>
    <description>FDA approved surgical procedure such as lamiectom and, laminotomy</description>
    <arm_group_label>HIVD-OP</arm_group_label>
    <arm_group_label>LSS w/o instability -OP</arm_group_label>
    <arm_group_label>LSS w/ instability - OP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>instrumentation and fusion</intervention_name>
    <description>FDA approved surgical procedure such as PLIF, ALIF, DLIF, OLI and TLIF</description>
    <arm_group_label>HIVD-OP</arm_group_label>
    <arm_group_label>LSS w/o instability -OP</arm_group_label>
    <arm_group_label>LSS w/ instability - OP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>codeine, oxycontine, IRcodone, Tramadol</intervention_name>
    <description>FDA approved opioid drug such as codeine, oxycontin, IRcodon</description>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_label>No intervention group</arm_group_label>
    <other_name>opioid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>epidural adhesiolysis</intervention_name>
    <description>FDA approved epidural adhesiolysis with catheter or endoscope</description>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_label>No intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Herniated intervertebral disease, Low back pain over 6 weeks: if neurological deficit
             is combined early surgery is allowed; Over 18 years; Visual analogue pain score over
             5; Compatible findings in MRI and/or CT

          2. Lumbar spinal stenosis without instability, Low back pain over 3 months: if
             neurological deficit is combined early surgery is allowed; Over 18 years; Visual
             analogue pain score over 5; Compatible findings in MRI and/or CT; Without instability
             (15 degrees and 4mm motion)

          3. Lumbar spinal stenosis with instability, Low back pain over 3 months: if neurological
             deficit is combined early surgery is allowed; Over 18 years; Visual analogue pain
             score over 5; Compatible findings in MRI and/or CT; With instability (15 degrees and
             4mm motion)

          4. No surgical indication, Low back pain over 6 weeks: if neurological deficit is
             combined early surgery is allowed; Over 18 years; Visual analogue pain score over 5;
             Compatible findings in MRI and/or CT;

        Exclusion Criteria:

          1. Herniated intervertebral disease, Cauda equine syndrome; Instability (15degrees, 4mm
             motion); Fracture, pregnancy; Any comorbidities that preclude operation; Combined
             disease: Neuromuscular disease, parkinson's disease, inflammatory arthritis,
             symptomatic spinal tumor, myelopathy, spinal infection; Previous lumbar spinal
             surgery; Neurological deficit that necessitates surgery

          2. Lumbar spinal stenosis without instability, Cauda equine syndrome; Instability
             (15degrees, 4mm motion); Fracture, pregnancy Any comorbidities that preclude
             operation; Combined disease: Neuromuscular disease, parkinson's disease, inflammatory
             arthritis, symptomatic spinal tumor, myelopathy, spinal infection; Previous lumbar
             spinal surgery; Neurological deficit that necessitates surgery

          3. Lumbar spinal stenosis with instability, Cauda equine syndrome; Fracture, pregnancy;
             Any comorbidities that preclude operation; Combined disease: Neuromuscular disease,
             parkinson's disease, inflammatory arthritis, symptomatic spinal tumor, myelopathy,
             spinal infection Previous lumbar spinal surgery; Neurological deficit that
             necessitates surgery

          4. No surgical indication, Cauda equine syndrome; Fracture, pregnancy; Combined disease:
             Neuromuscular disease, parkinson's disease, inflammatory arthritis, symptomatic spinal
             tumor, myelopathy, spinal infection; Neurological deficit that necessitates surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun Kee Chung, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chun Kee Chung, Professor</last_name>
    <phone>+82-2-2072-2352</phone>
    <email>chungc@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chi Heon Kim, Ass prof.</last_name>
    <phone>+82-2-2072-3398</phone>
    <email>chiheon1@snu.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chi Heon Kim, MD, PhD</last_name>
      <phone>+82-2-2072-2358</phone>
      <email>chiheon1@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Chun Kee Chung, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2016</study_first_submitted>
  <study_first_submitted_qc>August 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2016</study_first_posted>
  <last_update_submitted>February 4, 2018</last_update_submitted>
  <last_update_submitted_qc>February 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Chun Kee Chung</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Low back pain</keyword>
  <keyword>Intervertebral Disc Degeneration</keyword>
  <keyword>Spinal stenosis</keyword>
  <keyword>Comparative Effectiveness Research</keyword>
  <keyword>Cost-Benefit Analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Aceclofenac</mesh_term>
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Codeine</mesh_term>
    <mesh_term>Cyclooxygenase 2 Inhibitors</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

